<< Back to News

System Formulary Update
Topical Antivirals

Situation

The Topical Antivirals class review standardization was approved in July 2022.

Background

The following products were reviewed: acyclovir topical cream/topical ointment, docosanol topical cream, penciclovir topical cream, cidofovir topical gel (extemporaneous).

Assessment/Recommendations

System P&T voted to include the following products on the UNC Health System Drug Formulary:

• Docosanol 10% topical cream
• Cidofovir 1% topical gel (extemporaneous)

As a result, the following products will be removed from the inpatient drug formulary:

• Acyclovir 5% topical cream
• Acyclovir 5% topical ointment

Formulary/Epic changes will Go-Live on Tuesday, September 6, 2022.